Everest Organics Share Price

Small Cap | Pharmaceuticals and health care | BSE: 524790

₹260.00 image8.45 (3.36 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 256.60

High (₹) 262.00

Low (₹) 256.05

Prev. Close (₹) 251.55

Volume 5,377

VWAP (₹) 220.08

ROCE (%) 9.12

Industry P/E 43.95

TTM P/E -60.75

P/B Ratio 4.54

Market Cap (₹) Cr.252.47

Dividend Yield (%)--

EPS (₹) 0.17

ROE0.30%

Sales Growth (%) 7.75

Profit Growth (%)-176.40

Day Range

262.00262.00

L
H

52 Week Range

110.00307.15

L
H

Historical Returns

Returns (6M)

91.11 %

Returns (1Y)

117.12 %

Returns (3Y)

28.02 %

Returns (5Y)

128.07 %

Returns (6M)

91.11 %

Returns (1Y)

117.12 %

Returns (3Y)

28.02 %

Returns (5Y)

128.07 %

SWOT Analysis

  • Growth in Net Profit Margin (QoQ)
  • Growth in Annual Net Profit with increasing Profit Margin (YoY)
  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 46.58

MFI 67.18

ATR 16.06

Commodity Channel Index -221.70

ROC125 60.49

ROC21 -15.10

Williams %R -96.99

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current223.40226.45228.90220.95217.90215.45212.40
Week Ago256.75264.70275.40246.05238.10227.40219.45
Month Ago259.70259.70259.70259.70259.70259.70259.70

EMA & SMA
info_icon

260.00

Current Price

EMA & SMApin

Bullish Moving Averages

18

Bearish Moving Averages

2

5 Day 240.71


9 Day 243.61


10 Day 244.99


12 Day 251.38


14 Day 251.51

20 Day 253.75


26 Day 256.08


50 Day 264.30


100 Day 201.05


200 Day 170.87

Deals & Announcements

Bulk and Block Deals

No bulk or block deals available.

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
05 Apr, 2023DR. SRIKAKARLAPUDI KRISHNAVENIAcquisition2,60,892BSE
27 Mar, 2023DR. SRIKAKARLAPUDI KRISHNAVENIAcquisition53,135BSE
23 Mar, 2023Srikakarlapudi KrishnaveniAcquisition53,135BSE
22 Feb, 2021BK ADVANCE & RESEARCHLLPAcquisition₹239.001,000BSE
19 Feb, 2021BK ADVANCE & RESEARCHLLPAcquisition₹237.222,000BSE
18 Feb, 2021BK ADVANCE & RESEARCHLLPAcquisition₹244.612,000BSE
18 Feb, 2021BK ADVANCE & RESEARCHLLPAcquisition₹240.602,000BSE
14 Feb, 2021BK ADVANCE & RESEARCHLLPAcquisition₹249.102,000BSE
25 Dec, 2020BK ADVANCE & RESEARCHLLPAcquisition₹270.70500BSE
24 Dec, 2020BK ADVANCE & RESEARCHLLPAcquisition₹250.63509BSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
27 May, 2022Rs.0.5000 per share(5%)Final Dividend15 Sept, 202201 Jan, 1970
14 Jun, 2021Rs.1.0000 per share(10%)Final Dividend08 Sept, 202101 Jan, 1970
08 Feb, 2021Rs.0.5000 per share(5%)Interim Dividend17 Feb, 202118 Feb, 2021

Announcements

DateSourceDetail
12 Mar, 2025BSE IndiaReceipt of Listing Approval from BSE Limited
18 Feb, 2025BSE IndiaIntimation of Korea Drug Master File (KDMF) approval for Company''s Rabeprazole Sodium API.
13 Feb, 2025BSE IndiaDeclaration of results of the postal ballot together with scrutinizers report
13 Feb, 2025BSE IndiaDeclaration of Voting Results of Postal Ballot is enclosed
11 Feb, 2025BSE IndiaEnclosed the Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024
11 Feb, 2025BSE IndiaOutcome of the Board Meeting held today is enclosed.
11 Feb, 2025BSE IndiaEnclosed the Un-audited financial results for the quarter and nine months ended December 31, 2024
05 Feb, 2025BSE IndiaEVEREST ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 ,inter alia, to consider and approve inter-alia, to transact the following item(s) of business:\r\n\r\na) to consider, approve and take on record the Un-audited financial results of the Company for the quarter and nine months ended December 31, 2024.\r\nb) to consider and take note of the limited review report of the statutory auditors of the Company for the quarter ended December 31, 2024.\r\n
22 Jan, 2025BSE IndiaCompliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
08 Jan, 2025BSE IndiaProceedings, Voting Results and Scrutinizer Report for the EGM held on January 08, 2025

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--06 Feb, 202511 Feb, 2025
OthersInter-alia, 1. Allotment of Convertible Warrants upto 2,63,157 & Equity Shares upto 17,10,526. 2. Other business matters.14 Jan, 202513 Jan, 2025
Preferential Issue of shares--17 Dec, 202412 Dec, 2024
Quarterly Results--09 Nov, 202413 Nov, 2024
Quarterly Results--09 Aug, 202413 Aug, 2024
Audited Results--22 May, 202427 May, 2024
Quarterly Results--05 Feb, 202409 Feb, 2024
Quarterly Results--07 Nov, 202311 Nov, 2023
Quarterly Results & A.G.M.--07 Aug, 202312 Aug, 2023
Audited Results--22 May, 202327 May, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Everest Organics

Everest Organics is a Public Limited Listed company incorporated on 19/02/1993 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24230TG1993PLC015426 and registration number is 015426. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 197.24 Cr. and Equity Capital is Rs. 8.00 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1993

Managing Director

Dr. Srikakarlapudi Sirisha

NSE Symbol

--

Everest Organics Management

NameDesignation
Mr. Ramakrishnam Raju KounparajuChairman & Ind.Director
Dr. Srikakarlapudi SirishaManaging Director
Mr. Srikakarlapudi HarikrishnaWhole Time Director
Mr. Kakarlapudi Sitarama RajuNon Executive Director
Mr. Venkatasatyanarayana Murthy ChayalyIndependent Director
Mr. Prasad Venkata Satya Sundara SrikakolapuIndependent Director
Mr. Akella ParvathisemDirector - Technical

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)
₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)
₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)
₹1,093.000 - ₹1,420.200

FAQs on Everest Organics

What is the share price of Everest Organics?

The share price of Everest Organics on 13 Mar, 2025 is ₹ 260.00.

What is 52W high and 52W low share price of Everest Organics?

The highest and lowest 52W share prices of Everest Organics are ₹ 307.150 and ₹ 110.000

What is the market cap of Everest Organics?

The market capitalization of Everest Organics as of 13 Mar, 2025 is ₹ 252.47 Crores

What is the P/E ratio of Everest Organics?

The current P/E ratio of Everest Organics as of 13 Mar, 2025 is 43.95

What is the PB ratio of Everest Organics?

The PB ratio of Everest Organics as of 13 Mar, 2025 is 4.54

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited